Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • APA vs GSK✓SelectedUSD · GSKAPA vs GSK performance historyLatest closeAs of-1.98%11/19
Stock and ETF performance explorer

APA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.9%
GSK return
+97.7%
Excess return
-106.6%
Maximum drawdown
-93.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.5%
7D-6.4%-4.7%-1.7%-4.9%
30D-10.1%-4.7%-5.4%-8.9%
3M+3.2%-8.8%+12.0%+5.9%
6M+10.4%-4.6%+15.0%+11.1%
YTD+87.6%+1.0%+86.6%+81.9%
1Y+90.8%+6.9%+84.0%+80.8%
3Y+35.6%+52.5%-17.0%+5.1%
5Y+100.2%+40.3%+59.9%+58.7%
All-8.9%+97.7%-106.6%-34.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling